North America Ophthalmology Drugs and Devices Market – Industry Trends and Forecast to 2029

Inhaltsverzeichnis anfordernInhaltsverzeichnis anfordern Mit Analyst sprechen Mit Analyst sprechen Jetzt kaufenJetzt kaufen Vor dem Kauf anfragen Vorher anfragen Kostenloser Beispielbericht Kostenloser Beispielbericht

North America Ophthalmology Drugs and Devices Market – Industry Trends and Forecast to 2029

  • Healthcare
  • Upcoming Reports
  • Dec 2021
  • North America
  • 150 Seiten
  • Anzahl der Tabellen: 220
  • Anzahl der Abbildungen: 60

North America Ophthalmology Drugs Devices Market

Marktgröße in Milliarden USD

CAGR :  % Diagram

Diagramm Prognosezeitraum
2023 –2029
Diagramm Marktgröße (Basisjahr)
MILLIONEN USD
Diagramm Marktgröße (Prognosejahr)
USD 132.07 Billion
Diagramm CAGR
%
Diagramm Wichtige Marktteilnehmer
  • Johnson & Johnson Private Limited
  • Alcon Vision LLC
  • Ellex Medical
  • Bausch & Lomb
  • orporated

North America Ophthalmology Drugs and Devices Market, By Devices (Surgical Device, Diagnostics and Monitoring Devices, Vision care),  Drug (Glaucoma Drugs, Retinal Disorder Drugs, Dry Eye Drugs, Allergic Conjunctivitis and Inflammation Drugs, Others), Delivery Type (Capsules and Tablets, Gels, Eye Drops, Eye Ointment, Eye Solutions), End Use (Hospitals, Diagnostic Centres, Others), Country (U.S., Mexico, Canada) Industry Trends and Forecast to 2029

North America Ophthalmology Drugs and Devices Market

Market Analysis and Insights : North America Ophthalmology Drugs and Devices Market

Data Bridge Market Research analyses that the North America ophthalmology drugs and devices market to be grow at a CAGR of 6.60% in the forecast period of 2022-2029 and is likely to reach the USD 51.64 billion by 2029.

The branch of medicine known as ophthalmology deals with the anatomy, body structure, and illnesses of the eyeball. An ophthalmologist is a doctor who specialises in the clinical and surgical treatment of eye problems. Ophthalmologists are both surgical and clinical experts because they perform operations on the eyes. The eye can detect a wide range of illnesses and ailments.

One of the major reasons likely to boost the growth and demand of the ophthalmology drugs and devices market is the rising prevalence of eye problems such as diabetic retinopathy and macular degeneration. The rise in the geriatric population and technological improvements in drug delivery techniques, are expected to propel the global ophthalmology drugs and devices market forward. Similarly, the increase in the prevalence of lifestyle related diseases such as obesity is expected to boost market growth. Furthermore, the rising incidences of eye organ diseases such as glaucoma and cataract and changing lifestyle are projected to contribute to the market's growth.

Moreover, increase in the investments for research and development activities and the presence of strong emerging pipeline drugs will create lucrative opportunities that will propel the ophthalmology drugs and devices market forward over the projection period.

However, high cost of devices and the dearth of health insurance in under-developed nations are expected to hinder the growth of the ophthalmology drugs and devices market. Also, patent expiration of blockbuster ophthalmic drugs and less awareness among population about eye diseases are just a few of the challenges that could stymie the ophthalmology drugs and devices market's growth.

This North America ophthalmology drugs and devices market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on North America ophthalmology drugs and devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

North America Ophthalmology Drugs and Devices Market Scope and Market Size

The North America ophthalmology drugs and devices market is segmented on the basis of devices, drug, delivery type and end-use. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • Based on devices, market is segmented into surgical devices, diagnostics and monitoring devices and vision care. Diagnostic and monitoring devices are further sub-segmented into optical coherence tomography, ophthalmic ultrasound imaging systems, fundus camera market, ophthalmoscopes, retinoscope, pachymeter, wavefront aberrometers, perimeters/visual field analyzer, autorefractors/phoropter, specular microscope, corneal topographers and other. Surgical devices are further sub-segmented into cataract surgery devices, glaucoma surgery devices, refractive surgery devices and vitreoretinal surgery devices. Vision care is further sub-segmented into contact lens and spectacles.
  • Ophthalmology drugs and devices market is segmented based on the drug into glaucoma drugs, retinal disorder drugs, dry eye drugs, allergic conjunctivitis and inflammation drugs and other drugs.
  • On the basis of delivery type, ophthalmology drugs and devices market is segmented into capsules and tablets, gels, eye drops, eye ointment and eye solutions.
  • On the basis of end-use, ophthalmology drugs and devices market is segmented into hospitals, diagnostic centres and others.

North America Ophthalmology Drugs and Devices Market Country Level Analysis

The North America ophthalmology drugs and devices market is analysed and market size insights and trends are provided by country, devices, drug, delivery type and end-use as referenced above.

The countries covered in the North America ophthalmology drugs and devices market report are U.S., Mexico, and Canada.

The country section of the North America ophthalmology drugs and devices market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

The North America ophthalmology drugs and devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for North America ophthalmology drugs and devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the North America ophthalmology drugs and devices market. The data is available for historic period 2010 to 2020.

Competitive Landscape and North America Ophthalmology Drugs and Devices Market Share Analysis

The North America ophthalmology drugs and devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, North America presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to North America ophthalmology drugs and devices market.

Some of the major players operating in the North America ophthalmology drugs and devices market are Johnson & Johnson Private Limited, Alcon Vision LLC, Ellex Medical, Bausch & Lomb Incorporated, ZEISS International, HOYA Corporation, Merck & Co., Inc., NIDEK CO., LTD, Novartis AG, Pfizer Inc, F. Hoffmann-La Roche Ltd, TOPCON CORPORATION and Ziemer Ophthalmic Systems, among others.


SKU-

Erhalten Sie Online-Zugriff auf den Bericht zur weltweit ersten Market Intelligence Cloud

  • Interaktives Datenanalyse-Dashboard
  • Unternehmensanalyse-Dashboard für Chancen mit hohem Wachstumspotenzial
  • Zugriff für Research-Analysten für Anpassungen und Abfragen
  • Konkurrenzanalyse mit interaktivem Dashboard
  • Aktuelle Nachrichten, Updates und Trendanalyse
  • Nutzen Sie die Leistungsfähigkeit der Benchmark-Analyse für eine umfassende Konkurrenzverfolgung
Demo anfordern

Forschungsmethodik

Die Datenerfassung und Basisjahresanalyse werden mithilfe von Datenerfassungsmodulen mit großen Stichprobengrößen durchgeführt. Die Phase umfasst das Erhalten von Marktinformationen oder verwandten Daten aus verschiedenen Quellen und Strategien. Sie umfasst die Prüfung und Planung aller aus der Vergangenheit im Voraus erfassten Daten. Sie umfasst auch die Prüfung von Informationsinkonsistenzen, die in verschiedenen Informationsquellen auftreten. Die Marktdaten werden mithilfe von marktstatistischen und kohärenten Modellen analysiert und geschätzt. Darüber hinaus sind Marktanteilsanalyse und Schlüsseltrendanalyse die wichtigsten Erfolgsfaktoren im Marktbericht. Um mehr zu erfahren, fordern Sie bitte einen Analystenanruf an oder geben Sie Ihre Anfrage ein.

Die wichtigste Forschungsmethodik, die vom DBMR-Forschungsteam verwendet wird, ist die Datentriangulation, die Data Mining, die Analyse der Auswirkungen von Datenvariablen auf den Markt und die primäre (Branchenexperten-)Validierung umfasst. Zu den Datenmodellen gehören ein Lieferantenpositionierungsraster, eine Marktzeitlinienanalyse, ein Marktüberblick und -leitfaden, ein Firmenpositionierungsraster, eine Patentanalyse, eine Preisanalyse, eine Firmenmarktanteilsanalyse, Messstandards, eine globale versus eine regionale und Lieferantenanteilsanalyse. Um mehr über die Forschungsmethodik zu erfahren, senden Sie eine Anfrage an unsere Branchenexperten.

Anpassung möglich

Data Bridge Market Research ist ein führendes Unternehmen in der fortgeschrittenen formativen Forschung. Wir sind stolz darauf, unseren bestehenden und neuen Kunden Daten und Analysen zu bieten, die zu ihren Zielen passen. Der Bericht kann angepasst werden, um Preistrendanalysen von Zielmarken, Marktverständnis für zusätzliche Länder (fordern Sie die Länderliste an), Daten zu klinischen Studienergebnissen, Literaturübersicht, Analysen des Marktes für aufgearbeitete Produkte und Produktbasis einzuschließen. Marktanalysen von Zielkonkurrenten können von technologiebasierten Analysen bis hin zu Marktportfoliostrategien analysiert werden. Wir können so viele Wettbewerber hinzufügen, wie Sie Daten in dem von Ihnen gewünschten Format und Datenstil benötigen. Unser Analystenteam kann Ihnen auch Daten in groben Excel-Rohdateien und Pivot-Tabellen (Fact Book) bereitstellen oder Sie bei der Erstellung von Präsentationen aus den im Bericht verfügbaren Datensätzen unterstützen.

Häufig gestellte Fragen

The North America Ophthalmology Drugs and Devices Market size will be worth USD 51.64 billion by 2029.
The North America Ophthalmology Drugs and Devices Market growth rate will be 6.60% by 2029.
The rising prevalence of eye problems such as diabetic retinopathy and rise in the geriatric population and technological improvements in drug delivery techniques are the growth drivers of the North America Ophthalmology Drugs and Devices Market.
The devices, drug, delivery type and end-use are the factors on which the North America Ophthalmology Drugs and Devices Market research is based.
The major companies in the North America Ophthalmology Drugs and Devices Market are Johnson & Johnson Private Limited, Alcon Vision LLC, Ellex Medical, Bausch & Lomb Incorporated, ZEISS International, HOYA Corporation, Merck & Co., Inc., NIDEK CO., LTD, Novartis AG, Pfizer Inc, F. Hoffmann-La Roche Ltd, TOPCON CORPORATION and Ziemer Ophthalmic Systems.